Correlation Between Quoin Pharmaceuticals and GT Biopharma
Can any of the company-specific risk be diversified away by investing in both Quoin Pharmaceuticals and GT Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quoin Pharmaceuticals and GT Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Quoin Pharmaceuticals Ltd and GT Biopharma, you can compare the effects of market volatilities on Quoin Pharmaceuticals and GT Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quoin Pharmaceuticals with a short position of GT Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quoin Pharmaceuticals and GT Biopharma.
Diversification Opportunities for Quoin Pharmaceuticals and GT Biopharma
0.47 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Quoin and GTBP is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Quoin Pharmaceuticals Ltd and GT Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GT Biopharma and Quoin Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quoin Pharmaceuticals Ltd are associated (or correlated) with GT Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GT Biopharma has no effect on the direction of Quoin Pharmaceuticals i.e., Quoin Pharmaceuticals and GT Biopharma go up and down completely randomly.
Pair Corralation between Quoin Pharmaceuticals and GT Biopharma
Given the investment horizon of 90 days Quoin Pharmaceuticals Ltd is expected to under-perform the GT Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Quoin Pharmaceuticals Ltd is 1.35 times less risky than GT Biopharma. The stock trades about -0.05 of its potential returns per unit of risk. The GT Biopharma is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 850.00 in GT Biopharma on September 12, 2024 and sell it today you would lose (546.00) from holding GT Biopharma or give up 64.24% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Quoin Pharmaceuticals Ltd vs. GT Biopharma
Performance |
| Timeline |
| Quoin Pharmaceuticals |
| GT Biopharma |
Quoin Pharmaceuticals and GT Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Quoin Pharmaceuticals and GT Biopharma
The main advantage of trading using opposite Quoin Pharmaceuticals and GT Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quoin Pharmaceuticals position performs unexpectedly, GT Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GT Biopharma will offset losses from the drop in GT Biopharma's long position.| Quoin Pharmaceuticals vs. Revelation Biosciences | Quoin Pharmaceuticals vs. Virax Biolabs Group | Quoin Pharmaceuticals vs. Neurobo Pharmaceuticals | Quoin Pharmaceuticals vs. Allarity Therapeutics |
| GT Biopharma vs. Allarity Therapeutics | GT Biopharma vs. Neurobo Pharmaceuticals | GT Biopharma vs. Virax Biolabs Group | GT Biopharma vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |